There were 270 women who became pregnant in the course of the Pfizer/BioNTech clinical trials. In the three months after emergency use authorization (EUA), 23 women had “spontaneous abortions,” a rate of 8.5 percent. In all of 2019, the U.S. rate of fetal death was 5.7 per 1,000, a rate of .57 percent. That amounts to a 15-fold increase in fetal death compared with the 2019 “control” group.